Ivivi Health Sciences LLC landed a $4 million new investment in the initial close of a Series A round of financing and converted a $5.5 million bridge loan to equity.
A second tranche of $4 million is expected by the end of May, according to the San Francisco company, which has developed FDA-cleared electrotherapy devices to reduce post-surgical pain and edema in orthopedic specialties.
No comments:
Post a Comment